Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells

European Journal of Pharmacology

Volumn 376, Issue 1-2, 1999, Pages 139-148

  Oi, Shinji ^a   Haneda, Takashi ^a   Osaki, Junzo ^a   Kashiwagi, Yusuke ^a   Nakamura, Yasuhiro ^a   Kawabe, Junichi ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Cardiac myocyte; Cholesterol; Hypertrophy; Ras

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CALPHOSTIN C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PRAVASTATIN; PROTEIN KINASE C INHIBITOR; PROTEIN P21; SIMVASTATIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARDIOMEGALY; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; DNA; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MYOCARDIUM; NAPHTHALENES; PRAVASTATIN; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, SPRAGUE-DAWLEY; RNA; SIMVASTATIN;

EID: 0033031662     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00282-4     Document Type: Article

References (41)

1. Avrush J., Zhang X., Kyriakis J. Raf meets Ras: completing the framework of a signal transduction pathway. Trends. Biochem. Sci. 19:1994;279-283.
2. Blenis J. Signal transduction via the MAP kinases. Proceed at your own RSK. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5589-5892.
3. Bogoyevitch M.A., Sugden P.H. The role of protein kinases in adaptational growth of the heart. Int. J. Biochem. Cell Biol. 28:1996;1-12.
4. Cesarone C.F., Bolognesi C., Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal. Biochem. 100:1979;188-197.
5. Corsini A., Raiteri M., Soma M., Fumagalli F., Paoletti R. Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol. Res. 23:1991;173-180.
6. Crews C.M., Alessandrini A., Erikson R.L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:1994;478-484.
7. Daum G., Tappe I.E., Fries H.W., Troppmair J., Rapp U.R. The ins and outs of Raf kinases. Trends Biochem. Sci. 19:1990;474-479.
8. Downward J., Graves J.D., Warne P.H., Rayter S., Cantrell D.A. Stimulation of p21 ras upon T-cell activation. Nature. 346:1990;719-723.
9. Duff J.L., Berk B.C., Corson M.A. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinase in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 188:1992;257-264.
10. Gibbs J.B. Ras C-terminal processing enzymes - new drug targets? Cell. 65:1991;1-4.
11. Hancock J.F., Magee A.I., Childs J.E., Mashall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
12. Haneda T., McDermott P.J. Stimulation of ribosomal RNA synthesis during hypertrophic growth of cultured heart cells by phorbol ester. Mol. Cell Biochem. 104:1991;169-177.
13. Kashiwagi Y., Haneda T., Osaki J., Miyata S., Kikuchi K. Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells. Hypertens. Res. 21:1998;109-119.
14. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-558.
15. Koga T., Fukuda K., Shimada Y., Fukami M., Koike H., Tsujita Y. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. Eur. J. Biochem. 209:1992;315-319.
16. Komai T., Shigehara E., Tokui T., Ishigami M., Kuroiwa C., Horiuchi S. Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem. Pharmacol. 243:1992;667-670.
17. Komuro I., Kaida T., Shibazaki Y., Kurabayashi M., Katoh Y., Hoh E., Takaku F., Yazaki Y. Stretching cardiac myocytes stimulates protooncogene expression. J. Biol. Chem. 265:1990;3595-3598.
18. Kyriakis J.M., App H., Zhang X.F., Banerjee P., Brautigan D.L., Rapp U.R., Avrush J. Raf-1 activates MAP kinase-kinase. Nature. 358:1992;417-421.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Maltese W.A. Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4:1990;3319-3328.
21. Maltese W.A., Defendini R., Green R.A., Sheridan K.M., Donley D.K. Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Clin. Invest. 76:1985;1748-1754.
22. McDermott P.J., Morgan H.E. Contraction modulates the capacity for protein synthesis during growth of neonatal heart cells in culture. Circ. Res. 64:1989;542-553.
23. Miyata S., Haneda T. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am. J. Physiol. 266:1994;2443-2451.
24. Morgan H.E., Baker K.M. Cardiac hypertrophy, mechanical, neural, and endocrine dependence. Circulation. 83:1991;13-25.
25. Morgan H.E., Earl D.C.N., Broadus A., Wolpert E.B., Giger K.E., Jefferson L.S. Regulation of protein synthesis in heart muscle: I. Effect of amino acid levels on protein synthesis. J. Biol. Chem. 246:1971;2152-2162.
26. Munro, H.N., Fleck, A., 1966. The determination of nucleic acids. In: Glick, D. (Ed.), Methods of Biochemical Analysis. Wiley, New York, pp. 113-176.
27. O'Donnell M.P., Kasiske B.L., Kim Y., Atluru D., Keane W.F. Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest. 91:1993;83-87.
28. Ohmura E., Wakai K., Isozaki O., Murakami H., Onoda N., Emoto N., Shimizu K., Tsushima T., Demura H., Robins R.K. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro cAMP in vitro. Br. J. Cancer. 67:1993;279-283.
29. Repko E.M., Maltese W.A. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J. Biol. Chem. 264:1989;9945-9952.
30. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527-532.
31. Sadoshima J., Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12:1993;1681-1692.
32. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J. 15:1996;775-787.
33. Satoh T., Nakafuku M., Kaziro Y. Function of ras as a molecular switch in signal transduction. J. Biol. Chem. 267:1992;24149-24152.
34. Schafer W.R., Kim R., Sterne R., Thorner J., Kim S.H., Rine J. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science. 245:1989;379-385.
35. Serajuddin A.T., Ranadive S.A., Mahoney E.M. Relative lipophilicities, solubilities, and structure - pharmacological considerations of 3-hydroxy-3- methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. J. Pharm. Sci. 80:1991;830-834.
36. Shirakabe K., Gotoh Y., Nishida E. A mitogen-activated protein (MAP) kinase activating factor in mammalian mitogen-stimulated cells is homologous to Xenopus M phase MAP kinase activator. J. Biol. Chem. 267:1992;16685-16690.
37. Thorburn A., Thorburn J., Chen S., Powers S., Shubeita H.E., Feramisco J.R., Chien K.R. Hras-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J. Biol. Chem. 268:1993;2244-2249.
38. Vliet A.K., Thiel G.C., Huisman R.H., Moshabe H., Yap S.H., Cohen L.H. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochem. Biophys. Acta. 1254:1995;105-111.
39. Willumsen B.M., Norris K., Papageorge A.G., Hubbert N.L., Lowy D.R. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J. 3:1984;2581-2585.
40. Yamazaki T., Komuro I., Kudoh S., Zou Y., Shiojima I., Mizuno T., Takano H., Hiroi Y., Ueki K., Tobe K., Kadowaki T., Nagai R., Yazaki Y. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 96:1995;438-446.
41. Zou Y., Komuro I., Yamazaki T., Aikawa R., Kudoh S., Shiojima I., Hiroi Y., Mizuno T., Yazaki Y. Protein kinase C, but not tyrosine kinase or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J. Biol. Chem. 271:1996;33592-33597.